
Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
Ursula Schmidt-Erfurth, Bora Eldem, Robyn Guymer, Jean-François Korobelnik, Reinier O. Schlingemann, Ruth Axer-Siegel, Peter Wiedemann, Christian Simader, Margarita Gekkieva, Andreas WeichselbergerVolume:
118
Année:
2011
Langue:
english
DOI:
10.1016/j.ophtha.2010.09.004
Fichier:
PDF, 985 KB
english, 2011